Prevalence of pulmonary histoplasmosis infection among Human Immunodeficiency Virus/Tuberculosis patients attending infectious diseases hospital, Kano, northwestern Nigeria

Submitted: 15 May 2023
Accepted: 21 June 2023
Published: 27 December 2023
Abstract Views: 92
PDF: 88
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Histoplasmosis is a disease with a global distribution and hyperendemic zones. The severity of the sickness is determined by the number of conidia inhaled and the host’s cellular immune system’s performance. This study aimed to determine the prevalence of pulmonary histoplasmosis infection among Human Immunodeficiency Virus (HIV) / Tuberculosis (TB) patients attending an infectious diseases hospital in Kano, Nigeria. The study is a cross-sectional hospital study, in which 203 intervieweradministered questionnaires were distributed, sputum samples were collected, and fungal culture was carried out. Identification and antifungal susceptibility for the test isolates were done using microscopic examination and agar disc diffusion. Data were analyzed using the Statistical Package for Social Sciences (SPSS) version 22.0. The prevalence of histoplasmosis was 5.4%. Of the 67 (33.0%) samples collected from TB patients, only 5 (2.5%) were positive for Histoplasma capsulatum, and of the 75 (37.0%) samples collected from HIV patients, only 4 (2.0%) were positive. The findings highlight the need for developing better diagnostic tools that will promptly make the diagnosis of the infection, especially in developing countries. Histoplasmosis can present with symptoms similar to other respiratory diseases, which may lead to delays in treatment, and increase the financial burden of managing the infection on the patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Christie A, Peterson JC. Histoplasmin sensitivity. The Journal of Pediatrics. 1946;29:417-32. DOI: https://doi.org/10.1016/S0022-3476(46)80161-6
Guedes HL, Guimaraes AJ, Muniz MD, et al. PCR assay for identification of Histoplasma capsulatum based on the nucleotide sequence of the M antigen. Journal of Clinical Microbiology. 2003;41:535-9. DOI: https://doi.org/10.1128/JCM.41.2.535-539.2003
Bhatti S, Vilenski L, Tight R, Smego Jr RA. Histoplasma endocarditis: clinical and mycologic features and outcomes. Journal of Infection. 2005;51:2-9. DOI: https://doi.org/10.1016/j.jinf.2004.10.002
MONBREUN W. The cultivation and cultural characteristics of Darling’s Histoplasma capsulatum. Amer. J. Trop. Med. 1934;14:93-126. DOI: https://doi.org/10.4269/ajtmh.1934.s1-14.93
Ehondor TO, Ibadin EE, Enodiana GO. Prevalence of Tuberculosis and HIV Among Pulmonary Tuberculosis Suspects in Benin City, Nigeria-A Three Year Review. African Journal of Biomedical Research. 2019;22:271-4.
Adenis A, Nacher M, Hanf M, et al. Tuberculosis and histoplasmosis among human immunodeficiency virus–infected patients: a comparative study. The American journal of tropical medicine and hygiene. 2014;90:216. DOI: https://doi.org/10.4269/ajtmh.13-0084
Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: an emerging or a neglected disease? PLoS neglected tropical diseases. 2018;12:e0006046.
Ocansey BK, Kosmidis C, Agyei M, et al. Histoplasmosis in Africa: Current perspectives, knowledge gaps, and research priorities. PLoS Neglected Tropical Diseases. 2022;16:e0010111. DOI: https://doi.org/10.1371/journal.pntd.0010111
Eme OI, Idike A. Census politics in Nigeria: an examination of 2006 population census. Journal of Policy and Development studies. 2015;9:47-72. DOI: https://doi.org/10.12816/0011166
McGowan KL. Specimen collection, transport, and processing: mycology. Manual of clinical microbiology. 2015:1944-54. DOI: https://doi.org/10.1128/9781555817381.ch114
Litt D, Slack MP, Nakamura T, et al. Evaluation of the World Health Organization Global Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Network’s Laboratory External Quality Assessment Programme, 2014-2019. Journal of Medical Microbiology. 2023;72:001644. DOI: https://doi.org/10.1099/jmm.0.001644
Nacher M, Adenis A, Mc Donald S, et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS neglected tropical diseases. 2013;7:e2319. DOI: https://doi.org/10.1371/journal.pntd.0002319
Adenis A, Nacher M, Hanf M, et al. HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority. PLoS neglected tropical diseases. 2014;8:e3100. DOI: https://doi.org/10.1371/journal.pntd.0003100
Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: an emerging or a neglected disease? PLoS Neglected Tropical Diseases. 2018;12:e0006046. DOI: https://doi.org/10.1371/journal.pntd.0006046
Oladele R, Otu AA, Olubamwo O, et al. Evaluation of knowledge and awareness of invasive fungal infections amongst resident doctors in Nigeria. Pan African Medical Journal. 2020;36. DOI: https://doi.org/10.11604/pamj.2020.36.297.23279
Diekema DJ, Pfaller MA. Utility of antifungal susceptibility testing and clinical correlations. InInteractions of yeasts, moulds, and antifungal agents: how to detect resistance. 2011.Totowa, NJ, USA: Humana Press. DOI: https://doi.org/10.1007/978-1-59745-134-5_8
Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2007:807-25. DOI: https://doi.org/10.1086/521259
De Oliveira HC, Assato PA, Marcos CM, et al. Paracoccidioides-host interaction: an overview on recent advances in the paracoccidioidomycosis. Frontiers in Microbiology. 2015;6:1319. DOI: https://doi.org/10.3389/fmicb.2015.01319
Deepe Jr GS. Modulation of Infection with Histoplasma capsulatum by Inhibition of Tumor Necrosis Factor–α Activity. Clinical infectious diseases. 2005;41:S204-7. DOI: https://doi.org/10.1086/429999
Oladele RO, Osaigbovo II, Akanmu AS, et al. Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria. Emerging Infectious Diseases. 2022;28:2261-9. DOI: https://doi.org/10.3201/eid2811.220542
Ekeng BE, Davies AA, Osaigbovo II, et al. Current Epidemiology of Histoplasmosis in Nigeria: A Systematic Review and Meta Analysis. Nigerian Postgraduate Medical Journal. 2023;30. DOI: https://doi.org/10.4103/npmj.npmj_311_22

How to Cite

Ibrahim, Sumayya Shuaibu, Isah Abubakar Aliyu, Taysir Ramadan, Umar Usman, Yusuf Mohammad Sabo, Firdausi Abubakar, Maryam Kabir Umar, and Mustapha Ahmed Yusuf. 2023. “Prevalence of Pulmonary Histoplasmosis Infection Among Human Immunodeficiency Virus Tuberculosis Patients Attending Infectious Diseases Hospital, Kano, Northwestern Nigeria”. Pyramid Journal of Medicine 6 (2). https://doi.org/10.4081/pjm.2023.341.